38 Comparison between patients with de novo acute heart failure and acute decompensation of chronic heart failure: data from the Italian Survey of acute heart failure

2006 ◽  
Vol 5 (1) ◽  
pp. 2-2
Author(s):  
G CACCIATORE ◽  
M PORCU ◽  
A MAGGIONI ◽  
D LUCCI ◽  
F OLIVA ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Acute Heart Failure ◽  
De Novo ◽  
Failure Data ◽  
Italian Survey ◽  
Acute Decompensation

scholarly journals ACUTE HEART FAILURE PATIENTS

2016 ◽  
Vol 23 (10) ◽  
pp. 1281-1287
Author(s):  
Naeem Asghar ◽  
Shakeel Ahmad ◽  
Muhammad Nazim ◽  
Hafiz Muhammad Faiq Ilyas ◽  
Muhammad Nouman Ahmad
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Acute Heart Failure ◽  
De Novo ◽  
Uncontrolled Hypertension ◽  
Diabetic Patients ◽  
Study Group ◽  
Acute Decompensation ◽  
History Of ◽  
Precipitating Factor

Objectives: The objective of the study is to identify the precipitating factorsamong the patients presenting with AHF (Acute Heart Failure). Study Design: Cross sectionalstudy. Setting: Punjab Institute of Cardiology, Lahore. Duration of Study: 6 months. From01-01-2007 to 30-06-2007. Methodology: The calculated sample size was 170 cases with 5%margin of error, 95% confidence level taking expected percentage of uncontrolled hypertensioni.e. 12% (least percentage among all precipitating factors). Results: In the study group, mostlypatients of AHF were young with mean age of 55 + 6.99 years, male (61.8%), Diabetic (53.5%)and have history of chronic Heart Failure (63.5%). In male the most common precipitating factorof AHF was ACS (39.04%) while in female uncontrolled hypertension (38.46%). Conclusion:In diabetic patients the most common precipitating factor of AHF was ACS (30.7%). In patientswith acute decompensation of chronic heart failure the most common precipitating factor wasnon-compliance of medication (30.55%) while in patients with de novo Acute Heart Failure itwas ACS (41.93%). ACS was the common precipitating factor of Acute Heart Failure (28.2%)among the study group irrespective of gender, diabetes and history of Heart Failure.

588 The prognostic role of anemia in acute heart failure. Data from the Italian survey on acute heart failure

2006 ◽  
Vol 5 (1) ◽  
pp. 134-134
Author(s):  
L SCELSI ◽  
L TAVAZZI ◽  
A MAGGIONI ◽  
D LUCCI ◽  
G CACCIATORE ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Prognostic Role ◽  
Failure Data ◽  
Italian Survey

scholarly journals Acute Heart Failure developed as worsening of Chronic Heart Failure is associated with increased mortality compared to de novo cases

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Vesna Degoricija ◽  
Matias Trbušić ◽  
Ines Potočnjak ◽  
Bojana Radulović ◽  
Sanda Dokoza Terešak ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Acute Heart Failure ◽  
De Novo

scholarly journals Acute decompensated heart failure: a study of nursing care

2020 ◽  
Vol 15 (3) ◽  
pp. 1-12
Author(s):  
Nicholas Woolfe Loftus ◽  
Tracey Bowden
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Pulmonary Oedema ◽  
Acute Heart Failure ◽  
Acute Decompensated Heart Failure ◽  
Clinical Signs ◽  
Decompensated Heart Failure ◽  
Medical Attention ◽  
Acute Decompensation ◽  
Care Study

This care study focuses on the initial acute phase of care for a patient with acutely decompensated heart failure. Heart failure is a syndrome characterised by clinical signs, such as pulmonary oedema, and symptoms, such as dyspnoea. Acute heart failure develops rapidly and requires urgent medical attention, unlike the slower insidious onset of chronic heart failure. Acute heart failure can be either new or acute decompensation of chronic heart failure. The patient presented with cardiogenic pulmonary oedema because of acute decompensation of his chronic heart failure. He agreed to medical management, which included continuous positive airway pressure, intra-arterial cannulation and a furosemide infusion. This treatment proved largely effective, but it may have been better if his furosemide infusion had been stopped sooner. The implications for practice are explored in this care study.

In hospital costs of acute heart failure patients in the Czech Republic

Open Medicine ◽  
2009 ◽  
Vol 4 (4) ◽  
pp. 483-489 ◽  
Author(s):  
Barbora Ondrackova ◽  
Roman Miklik ◽  
Jiri Parenica ◽  
Jindrich Spinar ◽  
Michal Sticha ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
De Novo ◽  
Hospital Costs ◽  
Signs And Symptoms ◽  
Cardiac Resynchronization ◽  
Flat Rate ◽  
Acute Decompensation ◽  
Cardiac Catheterizations ◽  
Revascularization Procedures

AbstractThe retrospective cost analysis estimates direct in-patient costs and length of stay (LOS) in hospital for acute heart failure (AHF). Patients were hospitalized with acute decompensation (ADHF) or de novo AHF in the Faculty Hospital Brno in 2005 and 2006. Burden incurred is divided to standard cardiology unit (SCU) and intensive care unit (ICU). In-patient care costs include flat rate of admission, stay and medicinal procedures. The pharmaceuticals are included in daily in-patient rate; angiography, revascularizations and antiarrhythmic interventions are calculated separately. In total, 734 patients (57% male, mean age 71.7 years) with AHF were analyzed. De novo AHF (58.6%) was more common than ADHF; according to the clinical classification AHF with mild signs and symptoms prevailed (46%). The overall direct hospital cost of all patients was €2.4 million, mean LOS was 8.3 days and mean in-patient cost was €3295 (including all interventions). Almost a half passed through both SCU and ICU with LOS 10.8 days; mean LOS in the SCU was 8.3 days with one-day cost of €55; mean LOS in the ICU was 3.4 days with one-day cost of €618. Total cost of cardiac catheterizations and revascularizations (50% patients) was almost a million; cost of antiarrhythmic interventions was €529216 (implantation of pacemaker, implantable cardioverter-defibrillator or cardiac resynchronization therapy with biventricular device; 6.9% patients). Mortality during hospitalization was 14.6%. AHF is associated with poor prognosis and high costs during hospital admission; the predominant contributors of high costs are revascularization procedures (39%), stay in the ICU (31%) and antiarrhythmic interventions (22%).

scholarly journals Are de novo acute heart failure and acutely worsened chronic heart failure two subgroups of the same syndrome?

2010 ◽  
Vol 138 (3-4) ◽  
pp. 162-169
Author(s):  
Marko Banovic ◽  
Zorana Vasiljevic-Pokrajcic ◽  
Bosiljka Vujisic-Tesic ◽  
Sanja Stankovic ◽  
Ivana Nedeljkovic ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Acute Heart Failure ◽  
De Novo ◽  
Left Ventricular ◽  
Clinical Severity ◽  
Left Ventricular Ejection ◽  
One Year ◽  
Common Manifestation

Introduction. Acute heart failure (AHF) is one of the most common diseases in emergency medicine, associated with poor prognosis and high in-hospital and long-term mortality. Objective. To investigate clinical presentation of patients with de novo AHF and acute worsening of chronic heart failure (CHF) and to identify differences in blood levels of biomarkers and echocardiography findings. Methods. This prospective study comprised 64 consecutive patients being grouped according to the onset of the disease into patients with the de novo AHF (45.3%), and patients with acute worsening of CHF (54.7%). Results. Acute congestion (60%) was the most common manifestation of de novo AHF, whereas pulmonary oedema (43.1%) was the most common manifestation of acutely decompensated CHF. Patients with acutely decompensated CHF had significantly higher blood values of creatinine (147.10 vs 113.16 ?mol/l; p<0.05), urea (12.63 vs 7.82 mmol/l; p<0.05), BNP (1440.11 vs 712.24 pg/ml; p<001) and NTproBNP (9097.00 vs 2827.70 pg/ml; p<0.01) on admission, and lower values of M-mode left ventricular ejection fraction (LVEF) during hospitalization (49.44% vs 42.94%; p<0.05). The follow-up after one year revealed still significantly higher BNP (365.49 vs 164.02 pg/ ml; p<0.05) and lower average values of both LVEF in patients with acutely worsened CHF (46.62% vs 54.41% and 39.52% vs 47.88%; p<0.05). Conclusion. Considering differences in clinical severity on admission, echocardiography and natriuretic peptide values during hospitalization and after one year follow-up, de novo AHF and acutely worsened CHF are two different subgroups of the same syndrome.

Sign in / Sign up

Export Citation Format

Share Document